{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T15:31:49Z","timestamp":1781451109175,"version":"3.54.1"},"reference-count":93,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is a chronic, immune-mediated skin condition marked by excessive cell growth and inflammation. Current therapies frequently have limitations, such as side effects and insufficient efficacy, emphasizing the need for safer, more effective options. Erianin (ERN), a naturally occurring bioactive molecule produced from\n                    <jats:italic>Dendrobium chrysotoxum<\/jats:italic>\n                    , has anti-inflammatory and antioxidant characteristics, although its therapeutic potential in psoriasis has not been fully investigated. The purpose of this investigation was to look into the protective benefits of ERN against psoriasis-like skin inflammation utilizing laboratory-based cell models and an imiquimod-induced psoriasis animal model. Human keratinocytes were subjected to pro-inflammatory cytokines\n                    <jats:italic>in vitro<\/jats:italic>\n                    to simulate psoriasis disease, and cell survival and proliferation were measured.\n                    <jats:italic>In vivo<\/jats:italic>\n                    , mice given ERN for 6 days demonstrated a significant decrease in skin thickness, inflammatory cell infiltration, and overall histopathological alterations. ERN reduced pro-inflammatory substances (IL-6, IL-17, IL-23, IL-1\u03b2), TNF-\u03b1, COX-2, and inducible nitric oxide synthase, while increasing anti-inflammatory cytokine IL-10 and antioxidant-related molecules. Additionally, ERN stimulated the Kelch-like ECH-associated protein 1- nuclear factor erythroid 2-related factor 2 signaling pathway, which is essential for cellular antioxidant defense. The results presented here demonstrate that ERN reduces psoriasis-like inflammation by modifying immunological responses and increasing antioxidant protection, pointing to its potential as a viable therapeutic agent for psoriasis treatment.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1139","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:58:43Z","timestamp":1752238723000},"source":"Crossref","is-referenced-by-count":3,"title":["Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling"],"prefix":"10.1515","volume":"20","author":[{"given":"Hongmei","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Fourth People\u2019s Hospital of Jinan, Jinan , 250031 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Children & Women\u2019s Healthcare of Jinan, Jinan , 271100 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025122123391360202_j_biol-2025-1139_ref_001","doi-asserted-by":"crossref","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol. 2022;13:880201.","DOI":"10.3389\/fimmu.2022.880201"},{"key":"2025122123391360202_j_biol-2025-1139_ref_002","doi-asserted-by":"crossref","unstructured":"Damiani G, Bragazzi NL, Karimkhani AC, Wu D, Alicandro G, McGonagle D, et al. The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med. 2021;8:743180.","DOI":"10.3389\/fmed.2021.743180"},{"key":"2025122123391360202_j_biol-2025-1139_ref_003","doi-asserted-by":"crossref","unstructured":"Man AM, Orasan MS, Hoteiuc OA, Olanescu-Vaida-Voevod MC, Mocan T. Inflammation and psoriasis: a comprehensive review. Int J Mol Sci. 2023;24(22):16095.","DOI":"10.3390\/ijms242216095"},{"key":"2025122123391360202_j_biol-2025-1139_ref_004","doi-asserted-by":"crossref","unstructured":"Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND. Update on psoriasis: A review. J Family Med Prim Care. 2020;9(1):20\u20134.","DOI":"10.4103\/jfmpc.jfmpc_689_19"},{"key":"2025122123391360202_j_biol-2025-1139_ref_005","doi-asserted-by":"crossref","unstructured":"Albanesi C, Madonna S, Gisondi P, Girolomoni G. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunology. 2018;9:1549.","DOI":"10.3389\/fimmu.2018.01549"},{"key":"2025122123391360202_j_biol-2025-1139_ref_006","doi-asserted-by":"crossref","unstructured":"Ni X, Lai Y. Crosstalk between keratinocytes and immune cells in inflammatory skin diseases. Explor Immunol. 2021;1(5):418\u201331.","DOI":"10.37349\/ei.2021.00028"},{"key":"2025122123391360202_j_biol-2025-1139_ref_007","doi-asserted-by":"crossref","unstructured":"Davis JS, Ferreira D, Paige E, Gedye C, Boyle M. Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev. 2020;33(3):10\u20131128.","DOI":"10.1128\/CMR.00035-19"},{"key":"2025122123391360202_j_biol-2025-1139_ref_008","doi-asserted-by":"crossref","unstructured":"Gupta S, Garbarini S, Nazareth T, Khilfeh I, Costantino H, Kaplan D. Characterizing outcomes and unmet needs among patients in the United States with mild-to-moderate plaque psoriasis using prescription topicals. Dermatol Ther. 2021;11:2057\u201375.","DOI":"10.1007\/s13555-021-00620-x"},{"key":"2025122123391360202_j_biol-2025-1139_ref_009","doi-asserted-by":"crossref","unstructured":"Luger T, Augustin M, Lambert J, Paul C, Pincelli C, Torrelo A, et al. Unmet medical needs in the treatment of atopic dermatitis in infants: An expert consensus on safety and efficacy of pimecrolimus. Pediatr Allergy Immunol. 2021;32(3):414\u201324.","DOI":"10.1111\/pai.13422"},{"key":"2025122123391360202_j_biol-2025-1139_ref_010","doi-asserted-by":"crossref","unstructured":"Kuang Y, Li Y, Lv C, Li M, Zhang Z, Chen Y, et al. Unmet needs and treatment preference of systemic treatments for moderate-to-severe psoriasis from the perspectives of patients and dermatologists in China. Dermatol Ther. 2024;14(5):1245\u201357.","DOI":"10.1007\/s13555-024-01159-3"},{"key":"2025122123391360202_j_biol-2025-1139_ref_011","doi-asserted-by":"crossref","unstructured":"Ple\u0144kowska J, Gabig-Cimi\u0144ska M, Mozolewski P. Oxidative stress as an important contributor to the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(17):6206.","DOI":"10.3390\/ijms21176206"},{"key":"2025122123391360202_j_biol-2025-1139_ref_012","doi-asserted-by":"crossref","unstructured":"Khan AQ, Agha MV, Sheikhan KSA, Younis SM, Al Tamimi M, Alam M, et al. Targeting deregulated oxidative stress in skin inflammatory diseases: An update on clinical importance. Biomed Pharmacother. 2022;154:113601.","DOI":"10.1016\/j.biopha.2022.113601"},{"key":"2025122123391360202_j_biol-2025-1139_ref_013","doi-asserted-by":"crossref","unstructured":"Wojcik P, \u0141uczaj W, Zarkovic N, Skrzydlewska E. Modulation of oxidative stress in psoriasis: Pathophysiology and therapy. In Modulation of oxidative stress. Italy: Academic Press; 2023. p. 255\u201378.","DOI":"10.1016\/B978-0-443-19247-0.00014-X"},{"key":"2025122123391360202_j_biol-2025-1139_ref_014","doi-asserted-by":"crossref","unstructured":"Tu W, Wang H, Li S, Liu Q, Sha H. The anti-inflammatory and anti-oxidant mechanisms of the KEAP1\/NRF2\/ARE signaling pathway in chronic diseases. Aging Dis. 2019;10(3):637.","DOI":"10.14336\/AD.2018.0513"},{"key":"2025122123391360202_j_biol-2025-1139_ref_015","doi-asserted-by":"crossref","unstructured":"Xu WD, Yang C, Huang AF. The role of Nrf2 in immune cells and inflammatory autoimmune diseases: a comprehensive review. Expert Opin Ther Targets. 2024;28(9):789\u2013806.","DOI":"10.1080\/14728222.2024.2401518"},{"key":"2025122123391360202_j_biol-2025-1139_ref_016","doi-asserted-by":"crossref","unstructured":"Helou DG, Martin SF, Pallardy M, Chollet-Martin S, Kerdine-R\u00f6mer S. NRF2 involvement in chemical-induced skin innate immunity. Front Immunol. 2019;10:1004.","DOI":"10.3389\/fimmu.2019.01004"},{"key":"2025122123391360202_j_biol-2025-1139_ref_017","doi-asserted-by":"crossref","unstructured":"Tian W, de la Vega MR, Schmidlin CJ, Ooi A, Zhang DD. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2). J Biol Chem. 2018;293(6):2029\u201340.","DOI":"10.1074\/jbc.RA117.000428"},{"key":"2025122123391360202_j_biol-2025-1139_ref_018","doi-asserted-by":"crossref","unstructured":"Kamel NM, El-Sayed SS, El-Said YA, El-Kersh DM, Hashem MM, Mohamed SS. Unlocking milk thistle\u2019s anti-psoriatic potential in mice: Targeting PI3K\/AKT\/mTOR and KEAP1\/NRF2\/NF-\u03baB pathways to modulate inflammation and oxidative stress. Int Immunopharmacol. 2024;139:112781.","DOI":"10.1016\/j.intimp.2024.112781"},{"key":"2025122123391360202_j_biol-2025-1139_ref_019","doi-asserted-by":"crossref","unstructured":"Panieri E, Telkoparan\u2010Akillilar P, Saso L. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. BioFactors. 2023;49(2):228\u201350.","DOI":"10.1002\/biof.1912"},{"key":"2025122123391360202_j_biol-2025-1139_ref_020","doi-asserted-by":"crossref","unstructured":"Boo YC. Natural Nrf2 modulators for skin protection. Antioxidants. 2020;9(9):812.","DOI":"10.3390\/antiox9090812"},{"key":"2025122123391360202_j_biol-2025-1139_ref_021","doi-asserted-by":"crossref","unstructured":"Wro\u0144ski A, W\u00f3jcik P. Impact of ROS-dependent lipid metabolism on psoriasis pathophysiology. Int J Mol Sci. 2022;23(20):12137.","DOI":"10.3390\/ijms232012137"},{"key":"2025122123391360202_j_biol-2025-1139_ref_022","doi-asserted-by":"crossref","unstructured":"Yu Q, Ke J, Xie B, Li N, Zhang M, Tang L, et al. Yinxieling attenuates psoriasis in mice by regulating oxidative stress and lipid mediators to correct immune cell disorder through the NF-\u03baB\/Nrf2 signaling pathways. J Tradit Complementary Med. 2024. 10.1016\/j.jtcme.2024.08.003.","DOI":"10.1016\/j.jtcme.2024.08.003"},{"key":"2025122123391360202_j_biol-2025-1139_ref_023","doi-asserted-by":"crossref","unstructured":"Al-Harbi NO, Nadeem A, Ansari MA, Al-Harbi MM, Alotaibi MR, AlSaad AM, et al. Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase. Int Immunopharmacol. 2017;46:1\u20138.","DOI":"10.1016\/j.intimp.2017.02.018"},{"key":"2025122123391360202_j_biol-2025-1139_ref_024","doi-asserted-by":"crossref","unstructured":"Al-Harbi NO, Nadeem A, Al-Harbi MM, Zoheir KM, Ansari MA, El-Sherbeeny AM, et al. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A\/IL-17 receptor signaling in a murine model. Immunobiology. 2017;222(2):128\u201336.","DOI":"10.1016\/j.imbio.2016.10.013"},{"key":"2025122123391360202_j_biol-2025-1139_ref_025","doi-asserted-by":"crossref","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Alqahtani F, Sobeai HMA, et al. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Biochimie. 2020;179:146\u201356.","DOI":"10.1016\/j.biochi.2020.09.023"},{"key":"2025122123391360202_j_biol-2025-1139_ref_026","doi-asserted-by":"crossref","unstructured":"Burlec AF, H\u0103ncianu M, Iv\u0103nescu B, Macovei I, Corciov\u0103 A. Exploring the therapeutic potential of natural compounds in psoriasis and their inclusion in nanotechnological systems. Antioxidants. 2024;13(8):912.","DOI":"10.3390\/antiox13080912"},{"key":"2025122123391360202_j_biol-2025-1139_ref_027","doi-asserted-by":"crossref","unstructured":"Lee YG, Jung Y, Choi HK, Lee JI, Lim TG, Lee J. Natural product-derived compounds targeting keratinocytes and molecular pathways in psoriasis therapeutics. Int J Mol Sci. 2024;25(11):6068.","DOI":"10.3390\/ijms25116068"},{"key":"2025122123391360202_j_biol-2025-1139_ref_028","doi-asserted-by":"crossref","unstructured":"Ma C, Gu C, Lian P, Wazir J, Lu R, Ruan B, et al. Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 Pathway activation and attenuating inflammatory signaling. Cell Death Dis. 2023;14(11):768.","DOI":"10.1038\/s41419-023-06234-9"},{"key":"2025122123391360202_j_biol-2025-1139_ref_029","doi-asserted-by":"crossref","unstructured":"Ogawa T, Ishitsuka Y. The role of KEAP1-NRF2 system in atopic dermatitis and psoriasis. Antioxidants. 2022;11(7):1397.","DOI":"10.3390\/antiox11071397"},{"key":"2025122123391360202_j_biol-2025-1139_ref_030","doi-asserted-by":"crossref","unstructured":"Li G, Zhang H, Lai H, Liang G, Huang J, Zhao F, et al. Erianin: a phytoestrogen with therapeutic potential. Front Pharmacol. 2023;14:1197056.","DOI":"10.3389\/fphar.2023.1197056"},{"key":"2025122123391360202_j_biol-2025-1139_ref_031","doi-asserted-by":"crossref","unstructured":"Qiao Q, Du Y, Xie L. Research advances of erianin: Source, production, biological activities and pharmacological properties. Pharmacol Res-Modern Chin Med. 2022;2:100059.","DOI":"10.1016\/j.prmcm.2022.100059"},{"key":"2025122123391360202_j_biol-2025-1139_ref_032","doi-asserted-by":"crossref","unstructured":"Zhang X, Hu L, Xu S, Ye C, Chen A. Erianin: A direct NLRP3 inhibitor with remarkable anti-inflammatory activity. Front Immunol. 2021;12:739953.","DOI":"10.3389\/fimmu.2021.739953"},{"key":"2025122123391360202_j_biol-2025-1139_ref_033","doi-asserted-by":"crossref","unstructured":"Jia Z, Yue W, Zhang X, Xue B, He J. Erianin alleviates cerebral ischemia-reperfusion injury by inhibiting microglial cell polarization and inflammation via the PI3K\/AKT and NF-\u03baB pathways. Int Immunopharmacol. 2024;141:112915.","DOI":"10.1016\/j.intimp.2024.112915"},{"key":"2025122123391360202_j_biol-2025-1139_ref_034","doi-asserted-by":"crossref","unstructured":"Xiang Y, Chen X, Wang W, Zhai L, Sun X, Feng J, et al. Natural product erianin inhibits bladder cancer cell growth by inducing ferroptosis via NRF2 inactivation. Front Pharmacol. 2021;12:775506.","DOI":"10.3389\/fphar.2021.775506"},{"key":"2025122123391360202_j_biol-2025-1139_ref_035","doi-asserted-by":"crossref","unstructured":"Yang A, Li MY, Zhang ZH, Wang JY, Xing Y, Ri M, et al. Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. J Ethnopharmacol. 2021;273:113598.","DOI":"10.1016\/j.jep.2020.113598"},{"key":"2025122123391360202_j_biol-2025-1139_ref_036","doi-asserted-by":"crossref","unstructured":"Li J, Ren F, Yan W, Sang H. Kirenol inhibits TNF-\u03b1-induced proliferation and migration of HaCaT cells by regulating NF-\u03baB pathway. Qual Assur Saf Crop Foods. 2021;13(4):44\u201353.","DOI":"10.15586\/qas.v13i4.968"},{"key":"2025122123391360202_j_biol-2025-1139_ref_037","doi-asserted-by":"crossref","unstructured":"Yue LU, Ailin W, Jinwei Z, Leng L, Jianan W, Li L, et al. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K\/Akt\/mTOR pathway. Phytomedicine. 2019;64:153054.","DOI":"10.1016\/j.phymed.2019.153054"},{"key":"2025122123391360202_j_biol-2025-1139_ref_038","doi-asserted-by":"crossref","unstructured":"Sangaraju R, Alavala S, Nalban N, Jerald MK, Sistla R. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB\/c mice via down regulating NF-\u03baB and activation of Nrf2 signaling pathways. Int Immunopharmacol. 2021;96:107754.","DOI":"10.1016\/j.intimp.2021.107754"},{"key":"2025122123391360202_j_biol-2025-1139_ref_039","doi-asserted-by":"crossref","unstructured":"Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206\u20139.","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"2025122123391360202_j_biol-2025-1139_ref_040","doi-asserted-by":"crossref","unstructured":"Zhao Z, Liu T, Zhu S, Pi J, Guo P, Qi D, et al. Natural medicine combined with nanobased topical delivery systems: a new strategy to treat psoriasis. Drug Delivery Transl Res. 2022;12(6):1326\u201338.","DOI":"10.1007\/s13346-021-01031-3"},{"key":"2025122123391360202_j_biol-2025-1139_ref_041","doi-asserted-by":"crossref","unstructured":"Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci. 2019;20(10):2558.","DOI":"10.3390\/ijms20102558"},{"key":"2025122123391360202_j_biol-2025-1139_ref_042","doi-asserted-by":"crossref","unstructured":"Wei X, Liu J, Xu Z, Wang D, Zhu Q, Chen Q, et al. Research progress on the pharmacological mechanism, in vivo metabolism and structural modification of Erianin. Biomed Pharmacother. 2024;173:116295.","DOI":"10.1016\/j.biopha.2024.116295"},{"key":"2025122123391360202_j_biol-2025-1139_ref_043","doi-asserted-by":"crossref","unstructured":"Yan L, Zhang Z, Liu Y, Ren S, Zhu Z, Wei L, et al. Anticancer activity of erianin: Cancer-specific target prediction based on network pharmacology. Front Mol Biosci. 2022;9:862932.","DOI":"10.3389\/fmolb.2022.862932"},{"key":"2025122123391360202_j_biol-2025-1139_ref_044","doi-asserted-by":"crossref","unstructured":"Zhang HQ, Xie XF, Li GM, Chen JR, Li MT, Xu X, et al. Erianin inhibits human lung cancer cell growth via PI3K\/Akt\/mTOR pathway in vitro and in vivo. Phytother Res. 2021;35(8):4511\u201325.","DOI":"10.1002\/ptr.7154"},{"key":"2025122123391360202_j_biol-2025-1139_ref_045","doi-asserted-by":"crossref","unstructured":"Gong YQ, Fan Y, Wu DZ, Yang H, Hu ZB, Wang ZT. In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer. 2004;40(10):1554\u201365.","DOI":"10.1016\/j.ejca.2004.01.041"},{"key":"2025122123391360202_j_biol-2025-1139_ref_046","doi-asserted-by":"crossref","unstructured":"Ng TB, Liu F, Wang ZT. Antioxidative activity of natural products from plants. Life Sci. 2000;66(8):709\u201323.","DOI":"10.1016\/S0024-3205(99)00642-6"},{"key":"2025122123391360202_j_biol-2025-1139_ref_047","doi-asserted-by":"crossref","unstructured":"Singh SB. Discovery, synthesis, activities, structure\u2013activity relationships, and clinical development of combretastatins and analogs as anticancer drugs. A comprehensive review. Nat Product Rep. 2024;41(2):298\u2013322.","DOI":"10.1039\/D3NP00053B"},{"key":"2025122123391360202_j_biol-2025-1139_ref_048","doi-asserted-by":"crossref","unstructured":"Ahmad SF, Zoheir KM, Ansari MA, Korashy HM, Bakheet SA, Ashour AE, et al. Stimulation of the histamine 4 receptor with 4-methylhistamine modulates the effects of chronic stress on the Th1\/Th2 cytokine balance. Immunobiology. 2015;220(3):341\u20139.","DOI":"10.1016\/j.imbio.2014.10.014"},{"key":"2025122123391360202_j_biol-2025-1139_ref_049","doi-asserted-by":"crossref","unstructured":"Alzahrani KS, Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, El-Sherbeeny AM, et al. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. Biomed Pharmacother. 2016;111:347\u201358.","DOI":"10.1016\/j.biopha.2018.12.060"},{"key":"2025122123391360202_j_biol-2025-1139_ref_050","doi-asserted-by":"crossref","unstructured":"Singh S, Ramani P, Jayakumar ND, Pannu SJ, Sharma RK, Gill SS. Role of pro-inflammatory and anti-inflammatory cytokines in pathophysiology of psoriasis. Curr Oral Health Rep. 2022;9(4):132\u201345.","DOI":"10.1007\/s40496-022-00320-1"},{"key":"2025122123391360202_j_biol-2025-1139_ref_051","doi-asserted-by":"crossref","unstructured":"Mo C, Shetti D, Wei K. Erianin inhibits proliferation and induces apoptosis of HaCaT cells via ROS-mediated JNK\/c-Jun and AKT\/mTOR signaling pathways. Molecules. 2019;24(15):2727.","DOI":"10.3390\/molecules24152727"},{"key":"2025122123391360202_j_biol-2025-1139_ref_052","doi-asserted-by":"crossref","unstructured":"Mohd Noor AA, Azlan M, Mohd Redzwan N. Orchestrated cytokines mediated by biologics in psoriasis and its mechanisms of action. Biomedicines. 2022;10(2):498.","DOI":"10.3390\/biomedicines10020498"},{"key":"2025122123391360202_j_biol-2025-1139_ref_053","doi-asserted-by":"crossref","unstructured":"Li YL, Du ZY, Li PH, Yan L, Zhou W, Tang YD, et al. Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB\/c mice. Int Immunopharmacol. 2018;64:319\u201325.","DOI":"10.1016\/j.intimp.2018.09.015"},{"key":"2025122123391360202_j_biol-2025-1139_ref_054","doi-asserted-by":"crossref","unstructured":"Sharma A, Upadhyay DK, Gupta GD, Narang RK, Rai VK. IL-23\/Th17 axis: a potential therapeutic target of psoriasis. Curr Drug Res Rev Formerly: Curr Drug Abuse Rev. 2022;14(1):24\u201336.","DOI":"10.2174\/2589977513666210707114520"},{"key":"2025122123391360202_j_biol-2025-1139_ref_055","doi-asserted-by":"crossref","unstructured":"K\u00f6hler I. Innovative small-molecule therapies for psoriasis. Sweden: Linkopings Universitet; 2025.","DOI":"10.3384\/9789180758390"},{"key":"2025122123391360202_j_biol-2025-1139_ref_056","doi-asserted-by":"crossref","unstructured":"Fitch EL, Rizzo HL, Kurtz SE, Wegmann KW, Gao W, Benson JM, et al. Inflammatory skin disease in K5. hTGF-\u03b21 transgenic mice is not dependent on the IL-23\/Th17 inflammatory pathway. J Invest Dermatol. 2009;129(10):2443\u201350.","DOI":"10.1038\/jid.2009.88"},{"key":"2025122123391360202_j_biol-2025-1139_ref_057","doi-asserted-by":"crossref","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Ibrahim KE, et al. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T + tf\/J mice. Behav Brain Res. 2019;364:213\u201324.","DOI":"10.1016\/j.bbr.2019.02.031"},{"key":"2025122123391360202_j_biol-2025-1139_ref_058","doi-asserted-by":"crossref","unstructured":"Baki\u0107 M, Klisi\u0107 A, Koci\u0107 G, Koci\u0107 H, Karanikoli\u0107 V. Oxidative stress and metabolic biomarkers in patients with psoriasis. J Med Biochem. 2024;43(1):97.","DOI":"10.5937\/jomb0-45076"},{"key":"2025122123391360202_j_biol-2025-1139_ref_059","doi-asserted-by":"crossref","unstructured":"Klisic A, Bakic M, Karanikolic V. Comparative analysis of redox homeostasis biomarkers in patients with psoriasis and atopic dermatitis. Antioxidants. 2023;12(10):1875.","DOI":"10.3390\/antiox12101875"},{"key":"2025122123391360202_j_biol-2025-1139_ref_060","doi-asserted-by":"crossref","unstructured":"Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180\u20133.","DOI":"10.1016\/j.redox.2015.01.002"},{"key":"2025122123391360202_j_biol-2025-1139_ref_061","doi-asserted-by":"crossref","unstructured":"Liu S, He M, Jiang J, Xiaoru D, Bao C, Jingyu Z, et al. Triggers for the onset and recurrence of psoriasis: a review and update. Cell Commun Signal. 2024;22:108.","DOI":"10.1186\/s12964-023-01381-0"},{"key":"2025122123391360202_j_biol-2025-1139_ref_062","doi-asserted-by":"crossref","unstructured":"Winiarska-Mieczan A, Mieczan T, W\u00f3jcik G. Importance of redox equilibrium in the pathogenesis of psoriasis \u2013 impact of antioxidant-rich diet. Nutrients. 2020;12(6):1841.","DOI":"10.3390\/nu12061841"},{"key":"2025122123391360202_j_biol-2025-1139_ref_063","doi-asserted-by":"crossref","unstructured":"Chaiprasongsuk A, Panich U. Role of phytochemicals in skin photoprotection via regulation of Nrf2. Front Pharmacol. 2022;13:823881.","DOI":"10.3389\/fphar.2022.823881"},{"key":"2025122123391360202_j_biol-2025-1139_ref_064","doi-asserted-by":"crossref","unstructured":"Wu R, Zhang H, Zhao M, Li J, Hu Y, Fu J, et al. Nrf2 in keratinocytes protects against skin fibrosis via regulating epidermal lesion and inflammatory response. Biochem Pharmacol. 2020;174:113846.","DOI":"10.1016\/j.bcp.2020.113846"},{"key":"2025122123391360202_j_biol-2025-1139_ref_065","doi-asserted-by":"crossref","unstructured":"Br\u00fcck J, Dringen R, Amasuno A, Pau-Charles I, Ghoreschi K. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis. Exp Dermatology. 2018;27(6):611\u201324.","DOI":"10.1111\/exd.13548"},{"key":"2025122123391360202_j_biol-2025-1139_ref_066","doi-asserted-by":"crossref","unstructured":"Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Novel potential pharmacological applications of dimethyl fumarate \u2013 an overview and update. Front Pharmacol. 2023;14:1264842.","DOI":"10.3389\/fphar.2023.1264842"},{"key":"2025122123391360202_j_biol-2025-1139_ref_067","doi-asserted-by":"crossref","unstructured":"Reszke R, Szepietowski JC. A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis. Expert Opin Drug Saf. 2020;19(4):373\u201380.","DOI":"10.1080\/14740338.2020.1736553"},{"key":"2025122123391360202_j_biol-2025-1139_ref_068","doi-asserted-by":"crossref","unstructured":"Bojanowski K, Ibeji CU, Singh P, Swindell WR, Chaudhuri RK. A sensitization-free dimethyl fumarate prodrug, isosorbide di-(methyl fumarate), provides a topical treatment candidate for psoriasis. JID Innov. 2021;1(4):100040.","DOI":"10.1016\/j.xjidi.2021.100040"},{"key":"2025122123391360202_j_biol-2025-1139_ref_069","doi-asserted-by":"crossref","unstructured":"Ren J, Chen X, Wang HY, Yang T, Zhang KR, Lei SY. Gentiopicroside ameliorates psoriasis-like skin lesions in mice via regulating the Keap1-Nrf2 pathway and inhibiting keratinocyte activation. Acta Pharmacol Sin. 2025;46(5):1361\u201374.","DOI":"10.1038\/s41401-024-01449-8"},{"key":"2025122123391360202_j_biol-2025-1139_ref_070","doi-asserted-by":"crossref","unstructured":"Yang H, Du Z, Wang W, Song M, Sanidad K, Sukamtoh E, et al. Structure\u2013activity relationship of curcumin: Role of the methoxy group in anti-inflammatory and anticolitis effects of curcumin. J Agric Food Chemistr. 2017;65(22):4509\u201315.","DOI":"10.1021\/acs.jafc.7b01792"},{"key":"2025122123391360202_j_biol-2025-1139_ref_071","doi-asserted-by":"crossref","unstructured":"Mousavi SM, Milajerdi A, Sheikhi A, Kord\u2010Varkaneh H, Feinle\u2010Bisset C, Larijani B, et al. Resveratrol supplementation significantly influences obesity measures: a systematic review and dose\u2013response meta\u2010analysis of randomized controlled trials. Obes Rev. 2019;20(3):487\u201398.","DOI":"10.1111\/obr.12775"},{"key":"2025122123391360202_j_biol-2025-1139_ref_072","doi-asserted-by":"crossref","unstructured":"Rojo DLVM, Krajisnik A, Zhang DD, Wondrak GT. Targeting NRF2 for improved skin barrier function and photoprotection: focus on the achiote-derived apocarotenoid bixin. Nutrients. 2017;9(12):1371.","DOI":"10.3390\/nu9121371"},{"key":"2025122123391360202_j_biol-2025-1139_ref_073","doi-asserted-by":"crossref","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020;323(19):1945\u201360.","DOI":"10.1001\/jama.2020.4006"},{"key":"2025122123391360202_j_biol-2025-1139_ref_074","doi-asserted-by":"crossref","unstructured":"Salamito M, Gillet B, Syx D, Vaganay E, Malbouyres M, Cerutti C, et al. NRF2 shortage in human skin fibroblasts dysregulates matrisome gene expression and affects collagen fibrillogenesis. J Invest Dermatol. 2023;143(3):386\u201397.","DOI":"10.1016\/j.jid.2022.07.034"},{"key":"2025122123391360202_j_biol-2025-1139_ref_075","doi-asserted-by":"crossref","unstructured":"Petkovic M, Leal EC, Alves I, Bose C, Palade PT, Singh P, et al. Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway. J Nutr Biochem. 2021;98:108817.","DOI":"10.1016\/j.jnutbio.2021.108817"},{"key":"2025122123391360202_j_biol-2025-1139_ref_076","doi-asserted-by":"crossref","unstructured":"Silva LC, Ortigosa LC, Benard G. Anti-TNF-\u03b1 agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy. 2010;2(6):817\u201333.","DOI":"10.2217\/imt.10.67"},{"key":"2025122123391360202_j_biol-2025-1139_ref_077","doi-asserted-by":"crossref","unstructured":"Bagameri L, Botezan S, Bobis O, Bonta V, Dezmirean DS. Molecular insights into royal jelly anti-inflammatory properties and related diseases. Life. 2023;13(7):1573.","DOI":"10.3390\/life13071573"},{"key":"2025122123391360202_j_biol-2025-1139_ref_078","doi-asserted-by":"crossref","unstructured":"Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-\u03b1. Nature. 1987;329(6140):630\u20132.","DOI":"10.1038\/329630a0"},{"key":"2025122123391360202_j_biol-2025-1139_ref_079","doi-asserted-by":"crossref","unstructured":"Qu R, Chen X, Hu J, Fu Y, Peng J, Li Y, et al. Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-\u03b1\/NF-\u03baB signaling pathways. Sci Rep. 2019;9(1):1348.","DOI":"10.1038\/s41598-018-38174-2"},{"key":"2025122123391360202_j_biol-2025-1139_ref_080","doi-asserted-by":"crossref","unstructured":"Notarte KIR, Quimque MTJ, Macaranas IT, Khan A, Pastrana AM, Villaflores OB, et al. Attenuation of lipopolysaccharide-induced inflammatory responses through inhibition of the NF-\u03baB pathway and the increased Nrf2 level by a flavonol-enriched n-butanol fraction from Uvaria alba. ACS Omega. 2023;8(6):5377\u201392.","DOI":"10.1021\/acsomega.2c06451"},{"key":"2025122123391360202_j_biol-2025-1139_ref_081","doi-asserted-by":"crossref","unstructured":"Shukla R, Pandey V, Vadnere GP, Lodhi S. Role of flavonoids in management of inflammatory disorders. In Bioactive food as dietary interventions for arthritis and related inflammatory diseases. United Kingdom: Academic Press; 2019. p. 293\u2013322.","DOI":"10.1016\/B978-0-12-813820-5.00018-0"},{"key":"2025122123391360202_j_biol-2025-1139_ref_082","doi-asserted-by":"crossref","unstructured":"Oh JH, Kim SH, Kwon OK, Kim JH, Oh SR, Han SB, et al. Purpurin suppresses atopic dermatitis via TNF-\u03b1\/IFN-\u03b3-induced inflammation in HaCaT cells. Int J Immunopathol Pharmacol. 2022;36:03946320221111135.","DOI":"10.1177\/03946320221111135"},{"key":"2025122123391360202_j_biol-2025-1139_ref_083","doi-asserted-by":"crossref","unstructured":"Lee KS, Chun SY, Lee MG, Kim S, Jang TJ, Nam KS. The prevention of TNF-\u03b1\/IFN-\u03b3 mixture-induced inflammation in human keratinocyte and atopic dermatitis-like skin lesions in Nc\/Nga mice by mineral-balanced deep sea water. Biomed Pharmacother. 2018;97:1331\u201340.","DOI":"10.1016\/j.biopha.2017.11.056"},{"key":"2025122123391360202_j_biol-2025-1139_ref_084","doi-asserted-by":"crossref","unstructured":"Sunkari S, Thatikonda S, Pooladanda V, Challa VS, Godugu C. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms. Int Immunopharmacol. 2019;71:301\u201312.","DOI":"10.1016\/j.intimp.2019.03.035"},{"key":"2025122123391360202_j_biol-2025-1139_ref_085","doi-asserted-by":"crossref","unstructured":"Zhang JF, Bai KW, Su WP, Wang AA, Zhang LL, Huang KH, et al. Curcumin attenuates heat-stress-induced oxidant damage by simultaneous activation of GSH-related antioxidant enzymes and Nrf2-mediated phase II detoxifying enzyme systems in broiler chickens. Poult Sci. 2018;97(4):1209\u201319.","DOI":"10.3382\/ps\/pex408"},{"key":"2025122123391360202_j_biol-2025-1139_ref_086","doi-asserted-by":"crossref","unstructured":"Keleku-Lukwete N, Suzuki M, Yamamoto M. An overview of the advantages of KEAP1-NRF2 system activation during inflammatory disease treatment. Antioxid Redox Signal. 2018;29(17):1746\u201355.","DOI":"10.1089\/ars.2017.7358"},{"key":"2025122123391360202_j_biol-2025-1139_ref_087","doi-asserted-by":"crossref","unstructured":"Bardallo G, Panisello\u2010Rosell\u00f3 R, Sanchez\u2010Nuno A, Alva S, Rosell\u00f3\u2010Catafau N, Carbonell T. Nrf2 and oxidative stress in liver ischemia\/reperfusion injury. FEBS J. 2022;289(18):5463\u201379.","DOI":"10.1111\/febs.16336"},{"key":"2025122123391360202_j_biol-2025-1139_ref_088","doi-asserted-by":"crossref","unstructured":"Aladaileh SH, Abukhalil MH, Saghir SA, Hanieh H, Alfwuaires MA, Almaiman AA, et al. Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. 2019;9(8):346.","DOI":"10.3390\/biom9080346"},{"key":"2025122123391360202_j_biol-2025-1139_ref_089","doi-asserted-by":"crossref","unstructured":"Hosseini A, Masjedi A, Baradaran B, Hojjat\u2010Farsangi M, Ghalamfarsa G, Anvari E, et al. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis. J Cell Physiol. 2019;234(7):9943\u201355.","DOI":"10.1002\/jcp.27930"},{"key":"2025122123391360202_j_biol-2025-1139_ref_090","doi-asserted-by":"crossref","unstructured":"Phillips JT, Agrella S, Fox RJ. Dimethyl fumarate: a review of efficacy and practical management strategies for common adverse events in patients with multiple sclerosis. Int J MS Care. 2017;19(2):74\u201383.","DOI":"10.7224\/1537-2073.2015-086"},{"key":"2025122123391360202_j_biol-2025-1139_ref_091","doi-asserted-by":"crossref","unstructured":"Dinkova-Kostova AT, Copple IM. Advances and challenges in therapeutic targeting of NRF2. Trends Pharmacol Sci. 2023;44(3):137\u201349.","DOI":"10.1016\/j.tips.2022.12.003"},{"key":"2025122123391360202_j_biol-2025-1139_ref_092","doi-asserted-by":"crossref","unstructured":"Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169\u2013203.","DOI":"10.1152\/physrev.00023.2017"},{"key":"2025122123391360202_j_biol-2025-1139_ref_093","doi-asserted-by":"crossref","unstructured":"Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discovery. 2019;18(4):295\u2013317.","DOI":"10.1038\/s41573-018-0008-x"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1139\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1139\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T23:41:46Z","timestamp":1766360506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1139\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2025,8,20]]}},"alternative-id":["10.1515\/biol-2025-1139"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1139","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251139"}}